Navigation Links
Statement From Bayer(R) Aspirin Regarding the American Medical Association's New Aspirin Policy Resolution
Date:6/19/2008

a daily low-dose aspirin to prevent heart disease.

Aspirin is one of the most extensively studied drugs in history, with a 110-year track record of efficacy and safety. More than 200,000 patients have been studied in more than 200 randomized clinical trials evaluating aspirin efficacy and safety across a range of doses. When taken regularly, aspirin has been shown to significantly reduce the risk of heart attack and recurrent stroke. However, despite its well-established benefits, including support from guidelines recommendations by AHA, USPSTF, American Diabetes Association, World Health Organization and other health organizations, aspirin is widely underutilized in the United States and the world over. Reports show aspirin is used by only about half of those who should be using it to prevent CV events.

Bayer is committed to improving public health by promoting the safe and appropriate use of aspirin for CV event prevention. In addition to supporting numerous scientific studies in cardiovascular disease, Bayer has meaningful partnerships with many organizations, including AHA, PFP, WomenHeart: The National Coalition for Women with Heart Disease, and the National Stroke Association, to help raise awareness of the risks of CVD and ways to help control risk factors, including increasing the appropriate use of aspirin therapy.

About Bayer Consumer Care

The Consumer Care Division of Bayer HealthCare LLC, is headquartered in Morristown, N.J. Bayer's Consumer Care Division is among the largest marketers of over-the-counter medications and nutritional supplements in the world. Some of the most trusted and recognizable brands in the world today come from the Bayer portfolio of products. These include Bayer(R) Aspirin, ALEVE(R), Flanax(R)/Apronax(R), Alka-Seltzer Plus(R), Bactine(R), RID(R), Phillips'(R) Milk of Magnesia, Midol(R), Alka-Seltzer(R), Talcid(R), Rennie(R), Canesten(R), Bepanthen(R), Bepanthol(R), One A Day(R) vitamins, Flintstones(T
'/>"/>

SOURCE Bayer Consumer Care
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. National Campaign to Prevent Teen and Unplanned Pregnancy Statement on Jamie Lynn Spears
2. AAHSA Statement on Nursing Home Rating System
3. IPC The Hospitalist Company, Inc. Files Registration Statement for Proposed Offering
4. AHIP Statement on American Medical Association (AMA) Claims Processing Report
5. NCPA Statement on Senate Medicare Vote
6. Statement from Cleveland Clinic Regarding Pope Shenouda
7. Social Security Statement Advises Seniors to Consider Private Long-Term Care Insurance, LTC Agency Reports; Medicare Wont Cover It
8. XL Capital Ltd Issues Statement Regarding Merrill Lynch Lawsuit Against XL Capital Assurance Inc. (XLCA) a Subsidiary of Security Capital Assurance Ltd
9. Statement of Robert OConnor, M.D., M.P.H. Chair, American Heart Association, Emergency Cardiovascular Committee, on U.S. House of Representatives Passage of the Josh Miller HEARTS Act
10. NCPA Statement on Sen. Baucus Medicare Bill Inclusion of Solutions for Medicare and Medicaid Reimbursement Problems
11. Video: Zix Corporation Issues Statement Supporting Bipartisan Push for Medicare e-Prescribing Requirement
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations 2Health News:NARAL'S CHOICE: Is Anyone Surprised About Out-of-the-Mainstream NARAL's Choice of Barack Obama for President? 2Health News:NARAL'S CHOICE: Is Anyone Surprised About Out-of-the-Mainstream NARAL's Choice of Barack Obama for President? 3Health News:PA Homecare Association kicks off Annual Conference: Homecare advocates speak about the importance of re-balancing the healthcare system to ensure care to the citizens of the state 2Health News:World Vision Appealing for $2 Million for Deadly China Quake 2Health News:Study Supports Popular HIV Drug Regimen 2Health News:Study Supports Popular HIV Drug Regimen 3Health News:LIFE Foundation Launches Lifehappens.org to Help Consumers Make Smart Insurance-Buying Decisions 2Health News:LIFE Foundation Launches Lifehappens.org to Help Consumers Make Smart Insurance-Buying Decisions 3
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Anti epilepsy drug risk on cognitive function for unborn children 52256 1Anti epilepsy drug risk on cognitive function for unborn children 52256 2Go to the doctor 3F Only if Im really sick 52254 1Go to the doctor 3F Only if Im really sick 52254 2Researchers design first model motor nerve system thats insulated and organized like the human body 9298 1Researchers design first model motor nerve system thats insulated and organized like the human body 9298 2